2 news items
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
INCR
1 May 24
situation was declared by the Israeli government. As of this date, there is limited access to the Company's Southern Facility, and parts
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
INCR
1 Apr 24
situation was declared by the Israeli government. As of this date, there is limited access to the Southern Israel Site, and parts of the site are being
- Prev
- 1
- Next